ReviewEndocrine pathology2003
Practical markers used in the diagnosis of neuroendocrine tumors.
Review in Endocrine pathology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Gastric neuroendocrine tumors: A review of pathology and updated roadmap to surgical management.World journal of clinical oncology · 2025Review
- Presacral Neuroendocrine Neoplasms: A Multi-site Review of Surgical Outcomes.Annals of surgical oncology · 2024Article
- Appendiceal Well-Differentiated Neuroendocrine Tumors: A Single-Center Experience and New Insights into the Effective Use of Immunohistochemistry.International journal of surgical pathology · 2023Article
- Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Frontiers in surgery · 2023Review
- Aberrant synaptophysin expression in classic Hodgkin lymphoma.Diagnostic pathology · 2022Article
- Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq.Genome medicine · 2022Article
- NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells.Aging cell · 2022Article
- Case Report: Primary Intraosseous Poorly Differentiated Synovial Sarcoma of the Femur.Frontiers in oncology · 2022Article
- Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review.Abdominal radiology (New York) · 2021Review
- Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.Frontiers in endocrinology · 2021Article
- Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection.Diagnostic pathology · 2020Article
- The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.The oncologist · 2020Article
- Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.Journal of virology · 2020Article
- Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors.International journal of molecular sciences · 2020Article
- Comparing Deep Learning and Immunohistochemistry in Determining the Site of Origin for Well-Differentiated Neuroendocrine Tumors.Journal of pathology informatics · 2020Article
- Liver metastasis of a neuroendocrine neoplasm of unknown primary origin in a female patient with a history of breast cancer.Contemporary oncology (Poznan, Poland) · 2018Article
- Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2017Article
- Clinicopathological features of gastroenteropancreatic neuroendocrine tumors: A retrospective evaluation of 42 cases.Turkish journal of surgery · 2017Article
- Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.World journal of gastroenterology · 2015Review
- Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although there are many broad-spectrum neuroendocrine markers, chromogranin and synaptophysin are the principal ones used in diagnostic pathology. Other broad-spectrum neuroendocrine markers, transcription factors, and specific peptide markers used in the diagnosis of neuroendocrine tumors are reviewed. The use of different keratins in the differential diagnosis of endocrine tumors is also presented. The importance of using low-molecular-weight keratins such as CAM5.2 to avoid false-negative results in the workup of some neuroendocrine tumors is emphasized. Finally, the use of in situ hybridization in diagnostic pathology is briefly summarized.
Indexed as
Identifiers
14739487What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.